-+ 0.00%
-+ 0.00%
-+ 0.00%

SUTRO BIOPHARMA ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 TRIAL OF STRO-006, A NEXT-GENERATION ITGB6-TARGETING ADC, IN ADVANCED SOLID TUMORS

Reuters·10/21/2026 12:00:00

Please log in to view news